Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years
Novartis AG (NYSE:NVS) released new data Wednesday from the ALITHIOS open-label extension study. Data show first-line ...
News Medical on MSN7h
$1 Million Grant to Fund Research of Nerve Regeneration in Multiple Sclerosis Patients
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Early treatment significantly reduces long-term disability in children with multiple sclerosis, new study finds
New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that ...
Medindia7h
Early Treatment Cuts Long-Term Disability in Kids With Multiple Sclerosis
New research highlights the benefits of starting monoclonal antibody therapy for multiple sclerosis in childhood. The study, ...
US FDA approves injectable version of Roche's multiple sclerosis therapy
The U.S. Food and Drug Administration on Thursday approved Roche's under-the-skin injection to treat patients with multiple ...
Rutgers University2d
Testing a Revolutionary Treatment Against Progressive Multiple Sclerosis
Rutgers Health researchers will enroll primary or secondary progressive multiple sclerosis (p-MS) patients to see if an ...
Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...
Ancestry-specific genetic variants linked to multiple sclerosis risk
A study has uncovered novel ancestry-specific genetic variants linked to multiple sclerosis (MS), offering new insights that ...
News Medical1d
Study uncovers ancestry-specific genetic links to multiple sclerosis risk
A landmark study has uncovered novel ancestry-specific genetic variants linked to multiple sclerosis (MS), offering new insights that could reshape treatment approaches for diverse populations ...
China patent notification boosts PolTREG’s development of Treg cell therapy in multiple sclerosis
China’s National Intellectual Property Administration has issued notification to grant patent to PolTREG Chinese patent covers intrathecal ...
Medscape5d
Does Multiple Sclerosis Protect Against Alzheimer's?
Patients with MS showed half the rate of amyloid pathology compared with people without MS, suggesting a possible protective ...
Roche's OCREVUS ZUNOVO Gets FDA Approval To Treat Relapsing And Progressive Multiple Sclerosis
Swiss drug major Roche (RHHBY) announced Monday that the United States Food and Drug Administration has approved OCREVUS ZUNOVO ...